4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-012239
EVP, COO, HEAD OF COMMERCIAL sold 3,477 shares at $16.94 ($58,900)
- EVP, COO, HEAD OF COMMERCIAL acquired 6,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-05-01 | Option exercise | +6,814 | 45,610 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-05-02 | Sale | −3,477 | $16.94 | $58,900 | 42,133 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-05-01 | Option exercise · Restricted Stock Units | −6,814 | 20,445 | D | ||
| Open-market sales · 3,477 sh · avg $16.94 · $58,900 | |||||||
Loading xslF345X05/form4-05032024_060515.xml…